机译:Crizotinib在中国非小细胞肺癌患者脑转移中的疗效P3.01-103:多中心回顾性研究
Department of Medical Oncology National Cancer Center/cancer Hospital Chinese Academy of Medical;
Department of Medical Oncology National Cancer Center/cancer Hospital Chinese Academy of Medical;
Department of Medical Oncology National Cancer Center/cancer Hospital Chinese Academy of Medical;
Affiliated Tumor Hospital of Xinjiang Medical University;
Department of Medical Oncology National Cancer Center/cancer Hospital Chinese Academy of Medical;
Department of Respiratory Medicine Peking Union Medical College Hospital Peking Union Medical;
Department of Medical Oncology National Cancer Center/cancer Hospital Chinese Academy of Medical;
Affiliated Tumor Hospital of Xinjiang Medical University;
Second Affiliated Hospital of Harbin Medical University;
Peking University Third Hospital;
Department of Respiratory Medicine Peking Union Medical College Hospital Peking Union Medical;
Second Affiliated Hospital of Harbin Medical University;
Peking University Third Hospital;
Department of Medical Oncology National Cancer Center/cancer Hospital Chinese Academy of Medical;
机译:Crizotinib在中国非小细胞肺癌患者脑转移中的疗效P3.01-103:多中心回顾性研究
机译:De Novo在中国非小细胞肺癌患者和治疗疗效与克里齐替尼患者的扩增:多中心回顾性研究
机译:De Novo在中国非小细胞肺癌患者和治疗疗效与克里齐替尼患者的扩增:多中心回顾性研究
机译:细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
机译:非小细胞肺癌患者的临床结局:一项回顾性研究。
机译:来自现实世界的临床数据:克唑替尼在中国晚期ALK重排非小细胞肺癌和脑转移患者中的疗效
机译:来自现实世界的P2.03B-018临床资料:屈服尼在中国高级ALK +非小细胞肺癌和脑转移患者中的疗效